InvestorsHub Logo

The ELTP King

05/21/24 8:11 PM

#400429 RE: imanjen13 #400420

Pretty sure Vigabatrin manufacturing revenue will be included in the previous quarter (FY2024 Q4), which will be reported next month.

I think it's the same setup as Adderall XR with Prasco - revenue is recorded when they received the shipment.

Pyros launched the product April 1, which means we manufactured it in March or even before that.

Pyros launched its Vigpoder Vigabatrin generic in April; therefore the manufacturing revenue Elite receives will not be revealed until the current quarter's statement due in August.